Progress in peanut-allergy immunotherapy
As immunotherapy for peanut allergy advances, a Stanford allergy expert discusses what that means for parents, providers and the future of allergy treatments.
Possible therapy for surgical adhesions
Fibrous adhesions that form after abdominal surgery may be preventable or treatable, according to Stanford study. Adhesions affect most surgical patients, and treating them costs over $1 billion annually.
Home videos for autism diagnosis
Algorithms generated through machine learning can sort through observations of children’s behavior in short home videos to determine if the children have autism, a Stanford study has shown.
Algorithm success in screening for disease
In a matter of seconds, a new algorithm read chest X-rays for 14 pathologies, performing as well as radiologists in most cases, a Stanford-led study says.
Stanford Medicine magazine and high-tech
Stanford Medicine is applying high-tech approaches to reshape medical research, training, diagnostics and treatment — without losing the essential human touch.
EHRs for Fido
A team led by scientists at the School of Medicine has developed an algorithm that can read the typed-out notes from veterinarians and predict specific diseases that the animal may have.
New country, new bone marrow
Ikkei Takeuchi suffered from unexplained bone marrow failure. But with the help of his little brother and doctors at Lucile Packard Children’s Hospital Stanford, he’s on the road to recovery.
Air Cube touches down at hospital
The new Stanford Hospital gets its first commissioned piece of art.
No survival benefit with new cancer drug
Cisplatin chemotherapy can bring lasting adverse health effects, but a new, presumably less-toxic alternative is not as effective at promoting survival, according to a large, Stanford-led trial.
Farming linked to gut microbiome changes
Researchers at Stanford and several other institutions have linked the gut ecosystems of four Himalayan groups to the extent of each group’s departure from a hunter-gatherer lifestyle.